Xin Lang Cai Jing·2026-03-27 06:53Core Viewpoint - Tiger Medical has seen a 5% increase in stock price, reaching 53.32 CNY per share, with a total market capitalization of 45.91 billion CNY, indicating a positive market trend for the company [1][4]. Company Overview - Tiger Medical Technology Co., Ltd. was established on December 15, 2004, and went public on August 17, 2012. The company is located in Hangzhou, Zhejiang Province, and specializes in providing professional clinical research services for domestic and international pharmaceutical and health-related products [1][4]. - The main business activities include I to IV phase clinical trial technical services, data management and statistical analysis, registration application, on-site clinical trial services, SMO services, medical testing services, medical documentation translation, medical imaging diagnosis services, and training services [1][4]. - The revenue composition of the main business is as follows: clinical trial-related services and laboratory services account for 52.60%, clinical trial technical services for 45.21%, and other services for 2.19% [1][4]. Fund Holdings - A fund under Shangyin Asset Management holds a significant position in Tiger Medical, with 69,700 shares representing 5.56% of the fund's net value, making it the third-largest holding [2][5]. - The fund, named Shangyin High-Quality Preferred 9-Month Holding Period Mixed A (013358), has a total scale of 64.89 million CNY and has experienced a loss of 2.83% this year, ranking 6408 out of 8898 in its category [2][5]. Fund Manager Performance - The fund manager, Chen Bo, has been in charge for 6 years and 55 days, managing assets totaling 841 million CNY. During his tenure, the best fund return was 93.67%, while the worst was -19.42% [3][7].